Accord Healthcare has added Lurasidone HCL tablets to its line of generic drugs. Accord's product is AB-rated to Sunovion Pharma's Latuda® and is being offered in 20mg, 40mg, 60mg, 80mg, and 120mg doses in 30-count bottles.
Lurasidone is an oral, atypical antipsychotic, which is a first-line treatment option for the management of schizophrenia in adults and adolescents. Atypical antipsychotics have lower potential for extrapyramidal side effects. Lurasidone rebalances dopamine and serotonin to improve thinking, mood, and behavior.